Megovalicin D
Megovalicin D has an effect against Bacillus Subtilis and Escherichia coli, and it also has the effect against Pseudomonas aeruginosa[1].
Product Specifications
CAS Number
[115932-35-9]
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
O=C(NC[C@@H](O)C[C@H](O)[C@H](O)CC/C(C)=C/C=C/[C@H](CC)CCCC(CCCC[C@@H](C)C[C@@H]1C)=O)[C@H](CCC)OC1=O
Molecular Formula
C34H59NO7
Molecular Weight
593.83
References & Citations
[1]S Miyashiro, et al. Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. I. Screening of antibiotics-producing myxobacteria and production of megovalicins. J Antibiot (Tokyo) . 1988 Apr;41 (4) :433-8.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15374786 1 Vial
Lentiviral human OR6K6 sgRNA gene knockout kit - Lentiviral human OR6K6 sgRNA gene knockout kit (plasmid)
Ask
View Details 